AMGN
Amgen Inc.
Amgen Inc. is a biopharmaceutical company with $188M in federal contracts, $44.7M in annual doctor payments, and direct executive branch exposure via Trump holdings.
Govt Dependence
65/100
Regulatory Density
85/100
Lobbying Intensity
20/100
Political Signal
NEUTRAL
BusinessWhat AMGN does
Amgen develops, manufactures, and markets human therapeutics for serious illnesses, primarily in oncology, cardiovascular, and inflammatory diseases. Revenue is driven by biologic drug sales, with significant government reimbursement via Medicare/Medicaid and federal research contracts. The company engages in physician education and promotional payments, totaling $44.7M in 2024 per get_political_influence.doctor_payments.
6 months past · 3 months futureAMGN activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
109 trading days ·
9 congressional trades shown
·
0 insider buys
·
3 13F filings
·
0 past bill actions
·
3 upcoming markups
Executive Branch ConflictsAMGN held by Trump-administration officials
1 cabinet/senior official reported AMGN positions in OGE Form 278 disclosures across 2 filings.
Lifetime Government AwardsAMGN federal contracts by year
$188M
total awarded · 2018–2023
3
contracts on file
2018
peak year ($154M)
Top contracts by award amount
$154.4M
Department of Health and Human Serv
2018-09-13
IGF::OT::IGF RTOR NUMBER: RTOR-CSF-0005 ACQUISITION OF COLONY STIMULAT
$26.4M
Department of Health and Human Serv
2019-09-26
THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATME
$7.3M
Department of Health and Human Serv
2023-08-28
NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED IN
6 years · 3 contracts
Smart Money · 13F HoldingsHedge funds holding AMGN
$5.46B
Total AMGN held by tracked 13F funds
40
Funds with AMGN positions
+40
Funds opened this quarter
Citadel Advisors
$499M
opened
2024-03-31
D.E. Shaw & Co.
$485M
opened
2024-12-31
Citadel Advisors
$447M
opened
2024-06-30
Citadel Advisors
$441M
opened
2025-03-31
Citadel Advisors
$437M
opened
2024-12-31
Citadel Advisors
$387M
opened
2025-06-30
Citadel Advisors
$370M
opened
2025-09-30
D.E. Shaw & Co.
$357M
opened
2025-03-31
32 more 13F positions tracked · quarterly delta charts available in member dashboard
Politicians Trading AMGNMembers of Congress with recent AMGN positions
16 politicians traded AMGN across 70 disclosed transactions totaling $1.1M (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just AMGN). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
14 buys
11 sells
$372K
2026-01-23
LOW · 0
Jefferson Shreve
4 buys
2 sells
$195K
2025-05-12
LOW · 0
Scott Franklin
6 buys
$182K
2024-08-07
LOW · 0
Maria Elvira Salazar
1 buy
1 sell
$65K
2026-04-17
LOW · 0
Tommy Tuberville
2 sells
$65K
2025-04-15
LOW · 8
Lisa C. McClain
2 buys
3 sells
$40K
2025-09-25
LOW · 0
David J. Taylor
1 buy
3 sells
$32K
2026-02-26
LOW · 10
Sheldon Whitehouse
4 sells
$32K
2025-09-04
LOW · 7
Mark R. Warner
2 sells
$16K
2026-04-07
LOW · 0
Robert P. Bresnahan
2 sells
$16K
2025-04-08
LOW · 0
Virginia Foxx
2 buys
$16K
2024-12-06
LOW · 1
Julia Letlow
1 buy
1 sell
$16K
2024-11-19
LOW · 1
Daniel Meuser
2 sells
$16K
2025-02-11
LOW · 1
Jared Moskowitz
2 buys
$16K
2025-04-16
LOW · 0
Emily Randall
2 sells
$16K
2025-01-06
LOW · 0
1 more politicians active in AMGN · full table in member dashboard
Congressional TradesWho in Congress is trading AMGN
2026-04-17
Maria Elvira Salazar
Sale
$15,001 - $50,000
2026-04-07
Mark R. Warner
Sale
$1,001 - $15,000
2026-04-06
Mark R. Warner
Sale
$1,001 - $15,000
2026-03-24
Maria Elvira Salazar
Purchase
$15,001 - $50,000
2026-02-26
David J. Taylor
Sale
$1,001 - $15,000
2026-01-23
Ro Khanna
Sale
$15,001 - $50,000
2026-01-16
David J. Taylor
Purchase
$1,001 - $15,000
2026-01-29
David J. Taylor
Sale
$1,001 - $15,000
2024-11-19
Julia Letlow
Sale
$1,001 - $15,000
420d late
2024-10-23
Julia Letlow
Purchase
$1,001 - $15,000
447d late
2025-12-03
David J. Taylor
Sale
$1,001 - $15,000
2025-10-24
(unknown)
purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-05-08
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting AMGNLive legislation impacting this stock
HR.1843 · 119th
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
HR.1288 · 118th
Holding Countries Accountable for Negligent Chemical and Biological Programs Act
HR.1352 · 118th
Increasing Access to Biosimilars Act of 2023
S.935 · 118th
Fair Accountability and Innovative Research Drug Pricing Act of 2023
HR.6897 · 118th
Synthetic Biology and Active Pharmaceutical Ingredients Act
HR.6903 · 118th
Stockpiling Active Pharmaceutical Ingredients Act
HR.7090 · 118th
To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.
HR.7174 · 118th
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates und
HR.153 · 117th
Protecting Consumer Access to Generic Drugs Act of 2021
HR.853 · 117th
Closing Loopholes for Orphan Drugs Act
Political ProfileWhere AMGN sits in Washington
[object Object]
STRUCTURAL: Strong committee alignment (Energy & Commerce chair Guthrie, Health ranking DeGette, Appropriations ranking Murray) and $188M federal contracts. EVIDENTIARY: Zero corporate insider buys in 180 days per get_corporate_insider_signal; mixed congressional trading with net sales (e.g., T000490 multiple sales). Net: Structural support offset by lack of insider conviction and mixed trading.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Prescription drug pricing legislationCongress"Lobbying filings touching this ticker show specific issue 'Prescription drug pricing.'"
Regulatory opportunities
-
Federal research and procurement contractsDepartment of Health and Human Services"get_government_precedent.federal_contracts_summary shows $188.1M total obligation from 3 contracts with DHHS."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for AMGN
PANNONE LOPES DEVEREAUX & O'GARA LLC · $9K general
Member intelligence layer
Live signals + predictions for AMGN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades AMGN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout AMGN & political exposure
Does Amgen Inc. (AMGN) hold federal contracts?
Yes. Amgen Inc. has 3 federal contract awards totaling $188,143,668, primarily from agencies including Department of Health and Human Services. See full contract list and amounts on this page.
Which Trump cabinet officials own AMGN stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in AMGN on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded AMGN stock?
408 congressional trades by 50 unique members of Congress, most recently on 2026-04-17. See the Congressional Trading panel for politician-by-politician breakdown.
What is AMGN political risk profile?
Government dependence: 65/100. Lobbying intensity: 20/100. Political signal: neutral. Donor party split: R 10% / D 90%.
How does GovGreed track AMGN political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. AMGN data is updated daily from these official federal sources.